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The harm that pathogens cause to hosts during infection, termed virulence,
varies across species from negligible to a high likelihood of rapid death.
Classic theory for the evolution of virulence is based on a trade-off between
pathogen growth, transmission and host survival, which predicts that higher
within-host growth causes increased transmission and higher virulence.
However, using data from 61 human pathogens, we found the opposite cor-
relation to the expected positive correlation between pathogen growth rate
and virulence. We found that (i) slower growing pathogens are significantly
more virulent than faster growing pathogens, (ii) inhaled pathogens and
pathogens that infect via skin wounds are significantly more virulent than
pathogens that are ingested, but (iii) there is no correlation between symp-
toms of infection that aid transmission (such as diarrhoea and coughing)
and virulence. Overall, our results emphasize how virulence can be influ-
enced by mechanistic life-history details, especially transmission mode,
that determine how parasites infect and exploit their hosts.
This article is part of the themed issue ‘Opening the black box: re-
examining the ecology and evolution of parasite transmission’.1. Introduction
There is huge variation across pathogen species in the harm they cause their hosts
during an infection (virulence). Some bacteria, such as Bacillus cereus, cause
humans mild nausea and diarrhoea for 24–48 h [1]. By contrast, other species
such as B. anthracis kill 90–100% of their human hosts, often within 48 h [2].
Over the last 30 years, there has been a proliferation of theoretical models
developed to explain this variation in virulence [3–12]. A fundamental assump-
tion in these models is that there is a trade-off between parasite growth and host
survival—a higher parasite growth rate increases parasite transmission rate, but
also increases host mortality (virulence) leading to a shorter transmission
period [3,7]. As a result of this trade-off, theory predicts that transmission
rates will be maximized at an intermediate growth rate, with the associated
levels of virulence being an unavoidable consequence. This theory has been
supported by a number of within-species studies which have examined either
the correlation between pathogen growth rate and virulence, or how virulence
evolves in response to changing conditions such as co-infection of multiple
parasite strains and host population structure [8,12–19].
By contrast, evidence that the trade-off theory explains the large differences
we observe across parasite species in virulence is lacking [12,18,20–22]. One poss-
ible explanation for why patterns of virulence across species have been difficult to
explain is that mechanistic interactions between hosts and parasites may vary
across species and swamp any simple relationship between growth rate and viru-
lence [10,12,18]. For example, if traits that have large fitness benefits to parasites
Table 1. Parasite life-history variables commonly suggested to inﬂuence virulence.
parasite life-history variable predicted effect on virulence
route of infection
how a parasite gets exposed and transmitted to new hosts
(i) in cases where virulence does not hinder transmission, such as when vectors
circumvent the need for an ambulatory host, a higher virulence can be
favoured [23–27].
(ii) transmission routes which lead to higher within-host strain diversity can
favour either higher [7] or lower [10] virulence.
symptoms of infections
whether the host’s symptoms of parasite infection aid parasite
transmission
virulence will be higher when virulence aids transmission [23–26].
immune subversion
whether a species can kill or survive within professional
immune cells (immune subverter) or not (non-immune
subverter)
investing in control of host immune system trades off with efﬁcient host resource
extraction, leading to reduced growth and virulence [28,29] or mechanisms of
pathogenesis that target the immune system will be correlated with relatively
high virulence because the beneﬁts of increased parasite growth and survival
will outweigh the cost of an increased host mortality [12].
facultative versus obligate parasitism
whether human infection is a required part of the life cycle of
the parasite (obligate) or not (facultative)
facultative species will be less adapted to infecting humans and so will cause
lower virulence [30]. Observation bias could distort this trend, if relatively more
virulent facultative infections were more likely to be studied.
quorum-sensing controlled virulence factors
whether the production of virulence factors is controlled
cooperatively
coordinated production of virulence factors leads to more efﬁcient host
exploitation that increases virulence by greater ‘force’ of attack [29,31] or
decrease virulence by avoiding unnecessary damage [29,32,33].
motility
the ability of a species to move (motility) and hence disperse
between areas within a host
motility facilitates dispersal and colonization leading to increased virulence
[34–37] or decreased virulence because motility appendages are costly to
make and facilitate clearance by host immune cells [38–40].
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infection aid transmission, or when parasite strategies used
to escape or modulate the immune system cause mortality,
then any effect of growth rate on virulence may be hidden if
such traits are not considered [12]. The apparent discord
between the predicted influence of growth rate on virulence
and the observed cross-species patterns in virulence may,
therefore, be resolved if the mechanisms via which parasite
are transmitted, as well as the way parasites evade host
immunity, are examined in concert with growth rate.
Here, we use comparative analyses to examine the relation-
ship between virulence, growth, transmission andmechanisms
to evade host immunity across 61 human pathogens. We first
tested whether virulence was positively correlated with para-
site growth rate, as commonly assumed by virulence theory.
We then examined whether virulence correlated with six life-
history variables that have previously been argued to influence
the mechanism of pathogenesis (table 1): (i) the route of
infection, which can influence the extent to which virulence
decreases parasite transmission; (ii) whether symptoms of
parasite infection aid parasite transmission; (iii) whether a
species can kill or survive within professional immune cells
(immune subversion); (iv) whether a species primarily requires
transmission to humans to complete its life cycle (obligate
human parasites) or not (facultative human parasites); (v)
whether the production of virulence factors is coordinated
cooperatively with signalling (quorum sensing); and (vi) the
ability of a species to move (motility) and hence disperse
between areas within a host. We also tangentially consider
how the number of infectious particles required to establishan infection (infective dose) covaries with growth rate, because
infective dose has previously been shown to be an important
determinant of virulence [29,41].2. Material and methods
(a) Collection of data from the literature
An issue in any comparative study is that patterns in the data are
highly sensitive to the choice of taxa, raising the question of
whether the results observed might be due to biases in the
data available. An obvious source of bias in our data collection
is that the parasites for which we have the most data are the
ones demanding medical intervention. Related to this is the
matter of how to score a pathogen when its symptoms and life
history vary widely across patients and infection routes: there
is likely a bias to record the worst types of infections by patho-
gens, with asymptomatic infections by the same parasite going
unrecorded (whether intentionally or unintentionally). Given
these limitations and to ensure our analysis was as informative
as possible, we restricted our dataset to only include species
for which other corresponding data were available. Specifically,
(i) we included only pathogens where we had in vitro growth
rate data of human isolates, although it is unclear to what
extent the strains had been ‘domesticated’ in the laboratory and
(ii) where multiple transmission routes were possible, we incor-
porated the infection route and symptoms described in the case
fatality rate data.
To minimize variation across patients, the case fatality rates
are estimates of fatality without treatment or other illnesses
and represent the number of cases of a disease ending in death
compared with the number of cases of the disease. We classified
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skin, inhalation or ingestion. We obtained data for case fatality
rate, route of infection, facultative versus obligate parasitism,
symptoms of infection and the number of pathogen cells
required to start an infection (infective dose) by searching (i)
databases from the United States Food and Drug Administration
[1], Health Canada [42] and the Center for Disease Control and
Prevention [43]; and (ii) direct searches in the empirical literature
using keyword searches in the ISI Web of Knowledge database,
Google Scholar and PubMed.
Because in vivo human infection data are unavailable and data
from other host species can differ, we used in vitro generation time
as a measure of parasite growth rate, with smaller generation
times implying a higher growth rate. Presumably, the in vitro con-
ditions are ideal for parasite growth, and so here we are analysing
‘maximum’ growth rate, rather than the growth rate within hosts.
Yet, all things being equal, we expect in vitro growth rate to be cor-
related with in vivo growth. In support of this, (i) in vitro growth
measures have been shown to correlate with genomic traits associ-
ated with fast growth (such as rRNA and tRNA copy number)
[44] and (ii) experimental evidence has found that in vitro and
in vivo growth are correlated within species [44,45]. Data on the
growth rate of pathogens (minimal generation times in hours)
were collected from the electronic supplementary material of
Vieira-Silva & Rocha [44] and Gama et al. [29] with some new
data from the primary literature. Rate data can be modelled as a
Poisson process once converted to counts per time. We, therefore,
transformed generation times into number of generations per
week for analytical purposes. The period of a week was chosen
as this resulted in little rounding error when data were converted
to whole number counts and is easily interpretable in a biological/
clinical setting. For interactions with the immune system, motility
and quorum sensing, we first followed the electronic supplemen-
tary material of Gama et al. [29], with new data from the primary
literature which we found by searching the aforementioned data-
bases. We have included all data and bibliographic references in
electronic supplementary material, table S6.
(b) Statistical methods
We analysed our data using multi-response Bayesian phylo-
genetic mixed models (MR-BPMMs) with Markov chain Monte
Carlo estimation in the R package MCMCglmm, v. 2.21 [46,47].
MR-BPMMs have three main advantages in the context of this
study. (i) They allow the phylogenetic variance and covariance
between multiple response variables to be modelled simul-
taneously, which enables both the phylogenetic and residual
(non-phylogenetic) correlations to be estimated while examining
the effects of other potentially influential explanatory variables
on all the response variables concurrently (e.g. estimates the
effect of the other life-history traits in our dataset on case fatality
rate, growth rate and infective dose simultaneously). (ii) In phy-
logenetic mixed models, explanatory variables for each species
are assumed to be fixed over evolutionary time and measured
without error. Including growth rate and infective dose as
response variables, as well as case fatality rate, makes it possible
to model the evolutionary change in these variables over time.
(iii) It relaxes the assumption of causality (e.g. that growth
rates predict case fatality rate) allowing for the possibility that
case fatality rate may feedback and influence the evolution of
growth rate.
To model the effects of phylogenetic history and account for
the non-independence of data arising due to common ancestry
between pathogen species, we generated a phylogeny of the
species in our dataset using the Structural Classification of Proteins
(SCOP) database v. 1.75 (http://supfam.org/SUPERFAMILY/cgi-
bin/genome_names.cgi). SCOP constructs phylogenetic trees on
the basis of structural protein similarities derived from wholegenome sequencing. Where more than one genome for a species
was available in the database, we selected genomes of human iso-
lates. The branch lengths of phylogenies produced by SCOP
represent divergence in protein structure and are non-ultrametric.
Models fit in MCMCglmm require trees to be ultrametric where
branch lengths provide some estimate of evolutionary time. We,
therefore, converted the tree to be ultrametric using the ‘chronopl’
function in the R package ‘ape’ v. 3.1.2 with root-to-tip length and
lambda set to 1 [48]. We modelled phylogenetic history in our
MR-BPMMs by fitting a variance–covariance matrix constructed
from the phylogenetic tree as a random effect where the corre-
lation in the response trait between two pathogen species is
inversely proportional to time since their most recent common
ancestor, assuming a Brownian model of evolution. To assess
the sensitivity of our models to branch length information, we
repeated our analyses with branch lengths set arbitrarily to be
equal to 1 and recovered the same qualitative results as presented
in electronic supplementary material, tables S1–S5.
We conducted four sets of analyses. First, we tested whether
there was a positive correlation between case fatality rate and
pathogen growth using a MR-BPMM with case fatality rate
(% deaths: binomial distribution) and generations per week
(number per week: Poisson’s distribution) as the response vari-
ables. We fitted separate intercepts for each response variable
as fixed effects and estimated the phylogenetic and residual cor-
relations between case fatality rate and generations per week by
fitting 2  2 unstructured covariance matrices as random effects.
Phylogenetic and residual correlations between traits were calcu-
lated as the posterior mode and 95% credible interval (CIs) of the
posterior distribution of variance in trait A/square root (variance
in trait A  variance in trait B). Correlations were considered stat-
istically significant when the 95% CI did not span 0 and less than
5% of posterior samples were greater or less than 0 (pMCMC ,
0.05) [46]. We quantified the amount of variation in response
variables explained by phylogenetic history by calculating the
posterior mode and CI of phylogenetic heritability (phylo-H2 ¼
phylogenetic variance/sum(phylogenetic variance þ residual
variance)). The results of this analysis are presented in electronic
supplementary material, table S1.
Second, as the majority of the species in our dataset are bac-
terial pathogens, we tested that the results in the first analysis
were not driven by a few distantly related taxa by repeating the
analysis only including data on bacteria. The results of this analy-
sis are presented in electronic supplementary material, table S2.
Third, we tested how the case fatality rate and pathogen
growth rate (and their correlation) were influenced by other
life-history and epidemiological factors by rerunning the first
analysis, but including immune subversion (two-level fixed
factor: yes versus no), infection route (three-level fixed factor:
ingestion, inhalation and skin), whether symptoms aid trans-
mission (three-level fixed factor: hinder, no effect, help),
pathogen motility (two-level fixed factor: yes versus no), if patho-
gens use quorum sensing to regulate their growth (two-level
fixed factor: yes versus no) and whether humans were obligate
or facultative hosts for pathogens (two-level fixed factor: yes
versus no) as fixed effects. The magnitude and statistical signifi-
cance of relationships between fixed effects and response traits
(case fatality rate and pathogen growth) was examined using
the posterior mode, 95% CI and pMCMC of fixed effects. The
results of this analysis are presented in electronic supplementary
material, table S3. As above, we also repeated the analysis only
including data on bacteria. The results of this analysis are
presented in electronic supplementary material, table S4.
Fourth, as it has previously been shown that infective dose is
an important determinant of case fatality rate and may covary
with pathogen growth rate [29,41], we repeated our third analy-
sis including infective dose as a third response variable (number
of pathogens required for infection: Poisson’s distribution with
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Figure 1. Virulence and growth rate. White circles are ingested parasites; grey
circles are inhaled parasites; black circles are parasites that infect via skin
wounds. Smaller generation times imply faster growth. We found a significant
negative relationship between case fatality rate (%) and generation time
(generations per week) (electronic supplementary material, tables S1 and S2).
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and residual correlations between case fatality rate, pathogen
growth rate and infective dose while testing for the influence of
life-history and epidemiological factors on these variables and
their relationships. We once again fitted separate intercepts for
each of the three response variables and estimated phylogenetic
and residual correlations between response traits by fitting 3  3
unstructured covariance matrices as random effects. The results
of this analysis are presented in electronic supplementary
material, table S5.
Prior to all analyses, we Z-transformed (mean ¼ 0, standard
deviation¼ 1) continuous fixed effects and converted two-level
fixed effects to binary coding 21, 1 so that we could directly
compare the magnitude of parameter estimates [49,50]. We ran
MR-BPMMs for 10 000 000 iterations with a burn-in of 5 000 000
and a thinning interval of 5000. We checked the convergence of
each analysis by manual inspection of the MCMC chains of the
posterior distribution and using the Gelman–Rubin statistic
(potential scale reduction factor, PSR) to compare within- and
between-chain variance [51] in the R package ‘coda’ [52]. We
examined the sensitivity of our results to prior specification
by repeating each analysis with two different priors:
an inverse-Gamma (V ¼ 1, n ¼ 0.002) and parameter extended
‘Fisher’ prior (V ¼ 1, n ¼ 1, a.m ¼ 0, a.V ¼ 1000). The results of
models were extremely similar regardless of prior specification,
but the convergence of models with the parameter extended
model was slightly better and so we present only results from
these models. The R code used to specify priors and fit MR-
BPMMs is presented in the electronic supplementary material.
All parameter estimates in electronic supplementary material,
tables S1–S5, are presented on the scale of the link function of
models (binomial ¼ logit, Poisson ¼ log).3. Results and discussion
(a) Virulence and growth rate
Our first aim was to test whether virulence is positively cor-
related with parasite growth rate. In contrast with the
standard assumption that increased parasite growth leads
to greater host mortality [3,7], we found the opposite that
there was a significant negative correlation between gener-
ation time and virulence (figure 1; electronic supplementary
material, table S1, p ¼ 0.009). This does not demonstrate
that the trade-off theory for virulence is inaccurate or does
not exist. The significant negative relationship between
growth rate and virulence could occur because other life-
history details that determine how parasites infect and exploit
their hosts change the predicted trade-off between growth,
transmission and virulence.
(b) Virulence and transmission
Our second aim was to examine whether parasite virulence
correlated with the route of infection, which can influence
the extent to which virulence decreases parasite transmission
between hosts for a number of reasons (table 1). For example,
it has been argued that vectors can circumvent the need for
ambulatory hosts for transmission and can lead to higher
strain diversity, both of which could lead to higher virulence
for vectored parasites [7,25,26]. We tested whether virulence
was higher in parasites where virulence aids transmission,
but found no significant relationship between virulence and
whether the host’s symptoms of infection hinder, have no
effect or help transmission (figure 2a; electronic supplemen-
tary material, table S3, all pMCMC, 0.05). However, wefound that inhaled pathogens result in significantly higher
virulence than ingested pathogens (figure 2b; electronic sup-
plementary material, table S3, pMCMC, 0.0001), but not
pathogens infecting via skin wounds (figure 2b; electronic
supplementary material, table S3, pMCMC ¼ 0.30). Patho-
gens infecting via skin wounds are also significantly more
virulent than ingested pathogens (figure 2b; electronic
supplementary material, table S3, pMCMC, 0.0001).
This pattern is different from a previous analysis, where
pathogens infecting via skin wounds were more virulent
than the other two types [41]. The difference between these
two studies is driven by differences in the data: we now
have a larger dataset with more-virulent inhaled pathogens
that were not included in the previous paper because we
had no infective dose data for them. Also, the majority of
our data now comprises bacteria, because there is a lack of
appropriate growth rate data for viruses. To check that
our results were not driven by data on under-represented
groups, we conducted the same analysis with just the bacteria
data that made up 82% of our dataset (Nspecies ¼ 50). We
obtained the same results for bacteria as we did when we ana-
lysed the entire dataset (electronic supplementary material,
tables S2 and S4).(c) Virulence and variation in parasite infection
strategies
Establishment of a successful infection is not just predicted to
depend on transmission and growth potential, but also on
other life-history details and epidemiological factors that
determine how parasites infect and exploit their hosts.
Frank & Schmid-Hempel [12] argued that mechanisms of
pathogenesis that target the immune system will be corre-
lated with relatively high virulence because the benefits of
increased parasite growth and survival will outweigh the
cost of increased host mortality. Whether a species is a facul-
tative or an obligate parasite of humans could matter because
facultative species might be less adapted to their hosts and
hence cause lower virulence [30]. Quorum sensing could
matter because it allows pathogens to produce virulence fac-
tors more efficiently [31], which could either facilitate a
greater attack on the host, or avoid unnecessary damage to
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Figure 2. Virulence and parasite transmission. The case fatality rate (%) was: (a) not correlated with how symptoms of infection affect (1, hinder; 2, no effect; 3,
help) transmission (electronic supplementary material, table S3) but (b) significantly higher in species transmitted via inhalation and wounded skin than ingestion.
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lence by facilitating dispersal and colonization, allowing
pathogens to counteract mucus flows and peristalsis [34–37].
Alternatively, motility could decrease virulence because
flagella mediate the activation of dendritic cells, greatly
reducing bacterial survival [38], are costly to make [39] and
facilitate phagocytosis [40,53].
We investigated whether parasites (i) can kill professional
phagocytes or can survive and/or replicate in the intracellu-
lar milieu of these cells, termed ‘immune subverters; (ii)
require (obligate parasites) or do not require (facultative para-
sites) a human host to complete their life cycle; (iii) use
quorum sensing to regulate the production of virulence
factors; and (iv) are motile within their host. Contrary to pre-
dictions, we found no significant relationship between
virulence and whether a parasite species is (i) capable of sub-
verting the immune system or not (electronic supplementary
material, figure S2a and table S3, pMCMC ¼ 0.27); (ii) a facul-
tative or obligate parasite (electronic supplementary material,
figure S2b and table S3, pMCMC ¼ 0.23); (iii) using quorum
sensing to control virulence factor expression (electronic sup-
plementary material, figure S2c and table S3, pMCMC ¼
0.43); or (iv) motile or not (electronic supplementary material,
figure S2d and table S3, pMCMC ¼ 0.19).(d) Infective dose and virulence
We previously found that the number of cells required to suc-
cessfully infect a host (infective dose) was significantly
negatively correlated with virulence [41], a pattern that we
find again in this extended dataset (figure 3a; electronic sup-
plementary material, table S5, pMCMC, 0.001). Our current
results suggest that this is because (i) infective dose is posi-
tively correlated with parasite growth (figure 3b; electronic
supplementary material, table S5, pMCMC ¼ 0.02)—this is
a phylogenetic correlation suggesting that infective dose
and parasite growth have coevolved over evolutionary time;
but (ii) faster growing parasites are less virulent (figure 1,
electronic supplementary material, table S1 pMCMC ¼
0.0009) than slower growing parasites. Hence, higher parasite
growth is correlated with higher infective dose, which is
correlated with lower virulence.
Gama et al. [29] previously found that immune subversion
was the most significant factor shaping variation in infective
dose among human pathogens. Consistent with this, we find
that immune subverting parasites have a significantly lowerinfective dose than parasites that do not subvert host immu-
nity (figure 3c; electronic supplementary material, table S5,
pMCMC, 0.001). This seems intuitive if we consider that,
from an individual parasite’s perspective, investing in control
of the host immune system trades off with efficient resource
extraction, leading to reduced growth [28,29]. Also, a parasite
that can subvert host immune cells presumably does not need
to outpace immune clearance in order to successfully estab-
lish an infection. Together these results suggest that the
correlation between growth and virulence (figure 1) maybe
the result of slow growing species adopting different infec-
tion strategies whereby they target the immune system
causing more damage. By contrast, fast growing parasites
with high infective doses do not kill or subvert professional
immune cells leading to a higher probability of recovery
from infection [12].
We also found that parasites that cooperatively control their
production of virulence factors (quorum-sensing controlled
virulence factors) have higher infective doses (figure 3d; elec-
tronic supplementary material, table S5, pMCMC¼ 0.008)
and grow significantly faster (electronic supplementary
material, figure S3b and table S5, pMCMC ¼ 0.05) than para-
sites that do not. This seems logical if we consider that
quorum sensing is dependent on population density and so
is likely most effective when infective dose is high and/or
when parasites reproduce quickly. Together with the fact that
fast growth is correlated with low virulence (figure 1), this
suggests that quorum-sensing parasites may be less virulent,
perhaps because their coordinated production of virulence
factors avoids unnecessary host damage [29,32,33].(e) Insights and conclusions
In general, there have been only a limited number of formal
comparative studies attempting to explain virulence across
a number of pathogen species [20,26,41,54–56]. An important
exception is Herre’s [20] work on fig wasp nematodes, which
showed higher virulence in species where there was a higher
chance of transmission. A key difference between our studies
is that the fig wasp nematodes all shared very similar life his-
tories, and so there were not the large mechanistic life-history
details that have been a focus of our study here. Indeed, the
absence of such variation is critical to Herre’s study by facil-
itating the influence of variation in only one key variable,
transmission rate. Our results indicate that when examining
parasites over broader taxonomic levels that encompass
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Figure 3. Correlates of infective dose. (a) The case fatality rate (virulence) was significantly higher in species with a lower infective dose (log). (b) The generation
time (generations per week) was significantly higher in species with a higher infective dose. White circles are ingested parasites; grey circles are inhaled parasites;
black circles are parasites that infect via skin wounds. (c) Infective dose was significantly lower in pathogens with immune subversion. (d ) Infective dose was
significantly higher in pathogens with coordinated production of virulence factors (electronic supplementary material, tables S3 and S5).
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relationship between transmission and virulence may not
be borne out.
A priori we might expect our correlations to give little
insight into causation. However, there are at least three impor-
tant reasons why a study of growth rate and virulence
correlates is pertinent. First, while the typical caveats apply
concerning data quality and correlation not necessarily reflect-
ing causation, obtaining alternative experimental data is
problematic because (i) it is almost impossible to conduct con-
trolled in vivo infections in humans, especially when many of
the pathogens of interest are classified as potential biowea-
pons, and (ii) interpolating results from model animal
infections is complicated by ethical constraints and variations
in disease patterns between different host species. Second,
there is a vast theoretical literature exploring virulence evol-
ution, with so many permutations, that it is difficult to see
the wood for the trees [57]. Distilling the available data to
identify broad-scale patterns could yield useful results, but
it has not been done previously with respect to growth rate
and virulence. It might be that a particular causal factor is
so important that it overwhelms all other variables, and the
correlation with that variable shines through. With infectious
diseases, this would be good to know, that is, a variable that
we wish to note above all others. Third, many verbal argu-
ments about virulence evolution have been made using
correlational support from a small number of pathogens,
mostly different strains of the same species [23–26]. To an
extent, our analysis weeds out some of these arguments,
suggesting that there perhaps was/is no basis for them.In conclusion, we found that (i) slower growing patho-
gens are significantly more virulent than faster growing
pathogens, (ii) inhaled pathogens and pathogens that
infect via skin wounds are significantly more virulent
than pathogens that are ingested, but (iii) there is no corre-
lation between symptoms of infection that aid transmission
(such as diarrhoea and coughing) and virulence. The ability
of comparative analyses to confirm some predicted relation-
ships with virulence while questioning the effect of other
variables highlights the utility of this approach in further
understanding the evolution of virulence in different
species under different epidemiological, ecological and
evolutionary settings.Data accessibility. The datasets and analysis coding supporting this
article have been uploaded as part of the electronic supplementary
material.
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